Psychosis

Psychiatry·MeSH: Psychotic Disorders

12 drugs in development·8 companies·5 clinical trials

Drug Pipeline by Phase

Phase 3(5)

Drug	Company
ACP-204	ACADIA PHARMACEUTICALS INC (ACAD)
Cannabidiol	Valneva SE (VALN)
ITI-1284-ODT-SL	Intra-Cellular Therapies, Inc. (ITCI)
karxt	Karuna Therapeutics, Inc. (KRTX)
xanomeline/trospium	GH Research PLC (GHRS)

Phase 2(2)

Drug	Company
iti-1284	Intra-Cellular Therapies, Inc. (ITCI)
ml-007c-ma	MapLight Therapeutics, Inc. (MPLT)

Phase 1(1)

Drug	Company
ov350	Ovid Therapeutics Inc. (OVID)

Preclinical(1)

Drug	Company
ov4071	Ovid Therapeutics Inc. (OVID)

Phase 4(3)

Drug	Company
KarXT	BRISTOL MYERS SQUIBB CO (BMY)
ocrelizumab infusion	GH Research PLC (GHRS)
Pimavanserin tartrate	ACADIA PHARMACEUTICALS INC (ACAD)

BioSniper tracks 12 drugs in development for Psychosis across 8 companies.

There are 5 clinical trials targeting Psychosis tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.